Dem. Wants Repeal Of $500M Amgen 'Fiscal Cliff' Gift

Law360, Washington (January 23, 2013, 4:21 PM EST) -- A Democratic congressman from Vermont introduced a House bill Wednesday that would repeal a $500 million Medicare exception windfall for Amgen Inc. and other kidney care companies that was included in so-called fiscal cliff legislation, saying taxpayers had been stuck with the company's tab.

Rep. Peter Welch blasted the provision in the fiscal cliff bill that delays a set of Medicare price restraints on Amgen's kidney drug Sensipar and other oral end-stage renal disease treatments for two years. Welch called it a “giveaway” that would cost...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.